GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sihuan Pharmaceutical Holdings Group Ltd (OTCPK:SHPHF) » Definitions » FCF Margin %

Sihuan Pharmaceutical Holdings Group (Sihuan Pharmaceutical Holdings Group) FCF Margin % : 3.59% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Sihuan Pharmaceutical Holdings Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sihuan Pharmaceutical Holdings Group's Free Cash Flow for the six months ended in Dec. 2023 was $4.1 Mil. Sihuan Pharmaceutical Holdings Group's Revenue for the six months ended in Dec. 2023 was $112.7 Mil. Therefore, Sihuan Pharmaceutical Holdings Group's FCF Margin % for the quarter that ended in Dec. 2023 was 3.59%.

As of today, Sihuan Pharmaceutical Holdings Group's current FCF Yield % is -1.84%.

The historical rank and industry rank for Sihuan Pharmaceutical Holdings Group's FCF Margin % or its related term are showing as below:

SHPHF' s FCF Margin % Range Over the Past 10 Years
Min: -25.1   Med: 28.79   Max: 52.1
Current: -5.15

During the past 13 years, the highest FCF Margin % of Sihuan Pharmaceutical Holdings Group was 52.10%. The lowest was -25.10%. And the median was 28.79%.

SHPHF's FCF Margin % is ranked worse than
60.92% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.675 vs SHPHF: -5.15

Sihuan Pharmaceutical Holdings Group FCF Margin % Historical Data

The historical data trend for Sihuan Pharmaceutical Holdings Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sihuan Pharmaceutical Holdings Group FCF Margin % Chart

Sihuan Pharmaceutical Holdings Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.83 -14.34 -3.36 -25.10 -5.16

Sihuan Pharmaceutical Holdings Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.22 1.93 -80.30 -11.83 3.59

Competitive Comparison of Sihuan Pharmaceutical Holdings Group's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Sihuan Pharmaceutical Holdings Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sihuan Pharmaceutical Holdings Group's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sihuan Pharmaceutical Holdings Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sihuan Pharmaceutical Holdings Group's FCF Margin % falls into.


Sihuan Pharmaceutical Holdings Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sihuan Pharmaceutical Holdings Group's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-13.435/260.572
=-5.16 %

Sihuan Pharmaceutical Holdings Group's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=4.051/112.719
=3.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sihuan Pharmaceutical Holdings Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of Sihuan Pharmaceutical Holdings Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sihuan Pharmaceutical Holdings Group (Sihuan Pharmaceutical Holdings Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sihuan Pharmaceutical Holdings Group Ltd (OTCPK:SHPHF) » Definitions » FCF Margin %
Comparable Companies
HKSE:01681 HKSE:01349 HKSE:02877 HKSE:06896 HKSE:03613 HKSE:06185 HKSE:02348 HKSE:02552 HKSE:01061 HKSE:02633 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
00460:Hong Kong
Address
Zhubang 2000 Business Centre, 22nd Floor, Building 4, West Balizhuang, Chaoyang District, Beijing, CHN, 100025
Website
https://www.sihuanpharm.com
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Digestive System, Anti-Infective, metabolism, Respiratory, Neurology, and Others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others to provide non- or minimally invasive medical aesthetics comprehensive solutions; the innovative medicine and other medicine segments; and the generic medicine segment.